Investment Rating - The investment rating for China Mobile has been downgraded from "Buy" to "Neutral" [1] Core Insights - Goldman Sachs states that China Mobile's current valuation is at a reasonable level, with the target price reduced from HKD 105 to HKD 88 [1] - The firm maintains a positive outlook on China Mobile's expansion from traditional telecom services to innovative businesses, despite a continuous slowdown in 5G telecom service growth [1] - Future optimism regarding the stock may arise from improvements in 5G user ARPU, better-than-expected growth in innovative businesses, or faster-than-expected progress in 6G telecom services [1] Summary by Relevant Sections - **5G Service Growth**: The latest data indicates that the number of new 5G base stations in China will be 8,000 lower than Goldman Sachs' previous estimates by December 2025. The firm expects a year-on-year decline in new 5G base stations of 8% and 7% for 2026 and 2027, respectively, reaching 540,000 and 500,000 [1] - **Innovative Business Growth**: The firm anticipates continued growth in innovative businesses, primarily supported by the expansion of large-scale computing power and the coverage of AI ecosystems [1]

Investment Rating - The report assigns a "Reduce" rating to Beijing Capital International Airport Co., Ltd. (00694) with a target price of HKD 2.4 [1] Core Insights - The company has forecasted a net loss ranging from RMB 600 million to RMB 760 million for the previous year, significantly exceeding market expectations of a loss of RMB 216 million [1] - Even excluding tax impacts, the estimated pre-tax loss is projected to be between RMB 480 million and RMB 560 million, which is still below expectations [1] - The estimated pre-tax loss for the fourth quarter of last year is between RMB 170 million and RMB 250 million, indicating a year-on-year increase in losses [1]

Investment Rating - The report assigns a "Buy" rating to the company, believing its current stock price is undervalued due to a high implied weighted average cost of capital of 12% [1] Core Insights - The report highlights that the company, Innovent Biologics, is expected to maintain its leading position in the Chinese biotechnology sector, driven by a strong pipeline of novel molecules targeting next-generation immuno-oncology [1] - Encouraging preliminary data has been obtained for IBI363, a PD-1/IL-2α bispecific antibody, which exhibits differentiated drug characteristics in immunotherapy and cold tumors [1] - The company's robust commercialization capabilities and deep collaboration with global partners, particularly Eli Lilly, are also emphasized as key strengths [1] Summary by Relevant Sections - **Investment Rating**: "Buy" rating with a target price of HKD 102.85 based on risk-adjusted discounted cash flow [1] - **Market Position**: Innovent Biologics is positioned as a leader in the Chinese biotech field, supported by a strong pipeline and strategic partnerships [1] - **Product Development**: IBI363 shows promising initial results, indicating potential for differentiation in the competitive landscape of immunotherapy [1] - **Commercialization Strength**: The company’s strong commercial capabilities and partnerships enhance its market prospects [1]

Investment Rating - The report assigns a "Buy" rating to Meitu Inc. with a target price of HKD 16, implying a projected price-to-earnings ratio of 33.1 times for 2027 [1] Core Insights - The report highlights that generative artificial intelligence has transformed Meitu from a "beautification tool" into an "AI photo and video generation and editing application," expanding its market from consumer entertainment to enterprise productivity tools, which is expected to drive growth in monthly active users, payment ratios, and average revenue per user (ARPU) [1] - Revenue for Meitu is projected to grow at a compound annual growth rate (CAGR) of 29% from 2025 to 2030, with enterprise/productivity revenue expected to account for 44% of total revenue by 2030, up from an anticipated 12% in 2025 [1] - The global AI video and image creative market is forecasted to grow at a CAGR of 44% from 2025 to 2030, reaching USD 39 billion, with Meitu's market share in AI video/image expected to rise to 2% and 17% by 2030, compared to 1% and 13% in 2025 [1]

Investment Rating - The report assigns a rating of "Buy" for the company [2]. Core Insights - MiniMax is a rare pure-play multimodal model company that focuses on advanced model and AI-native product development, serving over 200 million individual users and more than 100,000 enterprises globally [8][14]. - The company has developed a core multimodal model portfolio, including M2, Hailuo-02, and Speech-02, aiming to enhance efficiency and stability through further integration of multimodal capabilities [8]. - The company has established a scalable monetization model early on, achieving significant revenue growth and positive feedback loops between user scale and income [8]. - Revenue projections for 2025-2027 are estimated at $81 million, $209 million, and $393 million, respectively, with year-on-year growth rates of 164%, 159%, and 88% [8]. - The company is positioned for global market expansion, supported by its comprehensive product offerings and ongoing commercialization efforts [8]. Company Overview - MiniMax focuses on advanced model and AI-native product development, having launched its first large language model in 2022 and continuously iterating on its model capabilities [14]. - The company offers a diverse range of C-end native products and B-end open platforms, including intelligent agents, video/audio generation platforms, and API platforms [19]. - As of September 30, 2025, MiniMax's AI products have served over 200 million individual users and more than 100,000 enterprises across over 100 countries [14]. Financial Analysis - The company has seen rapid revenue growth, with revenue increasing from $3.46 million in 2023 to $30.52 million in 2024, and further to $53.44 million in the first three quarters of 2025, representing a year-on-year growth of 175% [44]. - Gross margin has improved, transitioning from a loss in 2023 to a gross profit of $3.74 million in 2024, with a gross margin of 12% [49]. - The company’s net loss rate has narrowed, indicating potential for profitability as model intelligence and monetization capabilities improve [52]. Industry Analysis - The AI industry is experiencing rapid advancements in large model technology, with significant growth potential and an evolving competitive landscape [56]. - Major players in the market are maintaining a high frequency of model iterations, enhancing their capabilities and performance [57]. - The shift from traditional discriminative AI to large language models is enabling a broader range of applications, including text, image, audio, and video generation [59].

Investment Rating - The investment rating for Baidu Group is "Buy" (maintained) [1] Core Views - Baidu's AI full-stack layout, including cloud, chips, and Robotaxi, is expected to drive a revaluation of the company's value. Despite short-term pressure on search business, the company is anticipated to reach a turning point in AI commercialization in 2026 due to the restructuring of C-end applications by the Wenxin large model, increased market share in the MaaS sector, and the successful business model of Apollo Go in cities like Wuhan [4][6][30] - The non-GAAP net profit forecast for 2025-2027 has been adjusted to 18.5 billion, 20 billion, and 22.4 billion yuan, respectively, reflecting a year-on-year growth rate of -31.6%, +8.6%, and +12.0%. The corresponding EPS is projected to be 6.4, 7.0, and 7.8 yuan, with the current stock price corresponding to PE ratios of 19.6, 18.1, and 16.2 times [4][7] Summary by Sections 1. Baidu Intelligent Cloud - The AI IaaS market is rapidly growing, with the public cloud market expected to reach 621.6 billion yuan in 2024, a year-on-year increase of 36.6%. The domestic public cloud IaaS market is projected to grow by 68.2% to 420.1 billion yuan [13][20] - Baidu's intelligent cloud revenue reached 6.2 billion yuan in Q3 2025, with a year-on-year growth of 21%. AI infrastructure, platform services, and public cloud revenue contributed 4.2 billion yuan, growing by 33% year-on-year [5][30] 2. Kunlun Chip - Kunlun Chip is positioned as a leader in domestic AI computing power, with plans for a public listing that could enhance valuation. The chip has been deployed in over 100 enterprises, including major banks and state-owned enterprises [31][32] - The company is expected to enter a growth phase in 2026, with significant orders from major clients, including a billion-level procurement order from China Mobile [36] 3. Robotaxi - Baidu's Robotaxi service, "Luo Bo Kua Pao," has achieved significant scale, with 3.1 million orders in Q3 2025, a 212% year-on-year increase. The service operates in 22 cities globally, with a total driving distance exceeding 240 million kilometers [6][49] - The cost of autonomous driving services is projected to fall below traditional transportation costs by 2026, making it more accessible for widespread adoption [44][55] 4. AI Applications and Marketing Services - AI-native marketing is expected to become a second growth curve for Baidu, with revenue from AI marketing services reaching 2.8 billion yuan in Q3 2025, a 262% year-on-year increase [58] - The integration of AI into existing applications is anticipated to enhance user engagement and increase the paid user rate for productivity tools, with significant revenue contributions from platforms like Baidu Wenku and cloud storage services [62]

Investment Rating - The report assigns a rating of "Buy" for the company [2]. Core Insights - MINIMAX is a rare pure-play multimodal model company that focuses on advanced model and AI-native product development, with a global strategy from its inception [8][14]. - The company has developed a core multimodal model portfolio, including M2, Hailuo-02, and Speech-02, and aims to enhance efficiency and stability through further integration of multimodal capabilities [8][14]. - The company has a strong user base, serving over 200 million individual users and more than 100,000 enterprises and developers across over 200 countries [14]. - Revenue is projected to grow significantly, with estimates of $81 million in 2025, $209 million in 2026, and $393 million in 2027, reflecting growth rates of 164%, 159%, and 88% respectively [7][8]. - The report suggests a reasonable value of HKD 572.68 per share based on a price-to-sales ratio of 110x for 2026 [8]. Summary by Sections Company Overview - MINIMAX is positioned as a leading player in the AI sector, focusing on advanced model development and AI-native products, with a strong emphasis on global market penetration [14][19]. - The company has launched various consumer and enterprise products, including intelligent agents and video/audio generation platforms, with a diverse revenue model [19][20]. Financial Analysis - The company has shown rapid revenue growth, with revenues increasing from $3.46 million in 2023 to $30.52 million in 2024, and further to $53.44 million in the first three quarters of 2025, representing a year-on-year growth of 175% [45][48]. - Gross margins have improved, transitioning from a loss in 2023 to a gross profit of $1.24 million in 2025, with gross margins reaching 23% [50][51]. - The net loss rate has narrowed, indicating potential for profitability as model intelligence and monetization capabilities improve [53]. Industry Analysis - The AI industry is experiencing rapid advancements in large model technology, with continuous iterations and improvements in model capabilities [57][58]. - The competitive landscape remains dynamic, with both domestic and international players actively releasing new models and enhancing their capabilities [58][60].

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [2] Core Insights - The company is crossing the profitability inflection point, with accelerated commercialization of AI applications and game category expansion [2] - Bilibili has successfully transformed from a niche community platform to a leading PUGC video platform, achieving historical highs in MAU and DAU, with 376 million and 117 million respectively as of Q3 2025 [4][23] - The business structure is optimized with dual drivers of advertising and gaming, contributing to revenue elasticity [5] - Financial performance has improved significantly, with the company achieving positive net profit in Q3 2024 and expected to turn profitable for the full year 2025 [6] Company Overview - Bilibili, established in 2009, has evolved into the largest PUGC video platform in China, characterized by a high barrier to entry and strong user engagement [4][16] - The platform has successfully expanded its user demographic, with the average user age increasing from 21 in 2018 to 26 currently, tapping into the Z+ generation [4] Business Structure - The company's revenue sources include value-added services, advertising, gaming, and IP derivatives, with value-added services being the largest revenue contributor [5][40] - Advertising revenue grew by 21% year-on-year in the first three quarters of 2025, significantly outperforming the industry average [5][52] - The gaming segment has seen a resurgence with the launch of the popular SLG mobile game "Three Kingdoms: Strategize the World," contributing to a substantial increase in gaming revenue [5][55] Financial Performance - The company's revenue has shown consistent growth, with total revenue expected to reach 26.83 billion yuan in 2024, reflecting a 19% year-on-year increase [70] - The gross margin and net margin have been improving since 2023, with the company achieving a quarterly profit for the first time in Q3 2024 [6][70] - Operating cash flow turned positive in 2023, indicating a healthy self-sustaining business model [6][75] Investment Logic - The company maintains its profit forecast, expecting adjusted net profits of 2.548 billion, 3.366 billion, and 4.576 billion yuan for 2025, 2026, and 2027 respectively, with corresponding PE ratios of 36, 27, and 23 [7] - The potential for growth in gaming and advertising is being enhanced by AI technology and a comprehensive content strategy, with significant upside potential in advertising revenue [7][100]

Investment Rating - The investment rating for the company is "Outperform" (maintained) [2] Core Insights - The company has crossed the profitability inflection point, with accelerated commercialization of AI applications and expansion in gaming categories [2] - Bilibili has established itself as the leading PUGV platform in China, successfully transitioning from a niche community to a comprehensive video platform, with a strong user base and high engagement metrics [4] - The business structure has been optimized, with advertising and gaming driving revenue growth, showcasing resilience and flexibility in revenue generation [5] - Financial performance has improved significantly, with the company expected to achieve profitability in 2025, marking a pivotal moment in its financial trajectory [6] - The investment logic indicates a short-term safety margin and long-term growth potential, with projected net profits for 2025, 2026, and 2027 at 2.548 billion, 3.366 billion, and 4.576 billion RMB respectively [7] Company Overview - Bilibili, founded in 2009, has evolved into the largest PUGC video platform in China, characterized by a high barrier to entry and strong user engagement [4][16] - As of Q3 2025, the platform's MAU and DAU reached 376 million and 117 million respectively, both historical highs, indicating strong user loyalty [4][23] Business Structure - The company's revenue is diversified across four main segments: value-added services, advertising, gaming, and IP derivatives, with value-added services being the largest revenue source [5][40] - Advertising revenue grew by 21% year-on-year in the first three quarters of 2025, significantly outperforming the industry average [5][52] Financial Performance - The company achieved a significant turnaround in financial performance, with a quarterly profit in Q3 2024 and expectations for full-year profitability in 2025 [6][70] - Operating cash flow turned positive in 2023, with further growth to 5.308 billion RMB in the first three quarters of 2025, indicating strong self-sustaining capabilities [6][70] User Ecosystem - The user demographic has expanded, with the average age increasing from 21 in 2018 to 26 in 2024, indicating a broader appeal and potential for monetization [88] - Monthly active paid users reached 35 million, reflecting a strong conversion of users into paying customers [88] Gaming Business - The gaming segment has seen a strategic shift from a focus on niche genres to broader IP categories, with the successful launch of the SLG game "Three Kingdoms: Strategy" contributing significantly to revenue growth [55][99] - The gaming revenue for the first three quarters of 2025 reached approximately 48.54 billion RMB, a year-on-year increase of nearly 27% [99] Advertising Business - The advertising segment has shown consistent growth, with revenue increasing from 0.817 billion RMB in 2019 to 8.189 billion RMB in 2024, and a 21% increase in the first three quarters of 2025 [52][70] Cost Management - Content costs are significantly lower than traditional long-video platforms, with only 10% of revenue allocated to content costs in 2024, compared to 75% for competitors [6][75] - The sales and marketing expense ratio has decreased to 16% in 2024, indicating a shift away from aggressive spending for growth [80]

Investment Rating - The report maintains a "Buy" rating for WuXi Biologics (2269 HK) with a target price of HK$54.23, representing a potential upside of 44% from the current price of HK$37.68 [1][10][11]. Core Insights - The company is expected to see revenue and profit growth in 2025, driven by global network expansion and digital transformation initiatives. The growth trend is anticipated to continue into 2026, supported by strong research services, leading platform recognition, and an increase in drug development projects [6][10]. - The number of projects is on the rise, with a total of 945 comprehensive projects expected by 2025, including 74 clinical phase III projects. The company has reported that bispecific antibodies are the fastest-growing and most profitable molecule type, contributing nearly 20% of revenue with over 120% year-on-year growth [7][10]. - The company is enhancing its global footprint, with about half of new projects in 2025 coming from the U.S. Strategic investments are being made in U.S. facilities to bolster production capacity [8][10]. Financial Summary - Revenue projections for 2025E, 2026E, and 2027E are RMB 21,176 million, RMB 25,175 million, and RMB 29,813 million, respectively, reflecting growth rates of 13.4%, 18.9%, and 18.4% [9][15]. - The expected earnings per share (EPS) for 2025E, 2026E, and 2027E are RMB 0.87, RMB 1.03, and RMB 1.20, respectively [2][9]. - The company’s market capitalization is approximately US$5.923 billion, with a current share count of 1,228 million [1][9]. Valuation - The report employs a two-stage DCF valuation method, resulting in a target price of HK$54.23, which corresponds to a P/E ratio of 49x for 2026, slightly above the industry average of 30x [11][12]. - The report highlights a WACC of 7.9% and a perpetual growth rate adjustment to 5%, indicating a positive long-term outlook for the company [11][12].